UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an early-phase oncolytic virus that could work like a turbocharged Bacillus ...

The vivid wing patterns of butterflies, once attributed to a gene, are now traced to an overlooked microRNA.